Merck KGaA, Darmstadt, Germany, raises forecast for full year 2021

Disclosure of inside information pursuant to Article 17 of the Regulation (EU) No 596/2014

03 Nov 2021 | Darmstadt, Germany

Today, Merck KGaA, Darmstadt, Germany, has published the following ad hoc news:

Based on a very strong third quarter of 2021 with net sales of EUR 4.97 bn resulting in EBITDA pre1 of EUR 1.55 bn and EPS pre1 of EUR 2.24, Merck KGaA, Darmstadt, Germany, (the “Company”) has further raised its forecast for the entire group for fiscal 2021. The main driver is a very strong operating performance from the Life Science business sector. The Company now projects net sales of approx. EUR 19.30 – 19.85 bn (previously EUR 18.80 – 19.70 bn). EBITDA pre1 is anticipated to grow to approx. EUR 6.0 – 6.3 bn for the group (previously “EUR 5.6 – 6.0 bn”). EPS pre1 is projected to amount to approx. EUR 8.50 – 9.00 (previously “EUR 7.80 – 8.50”).

The Company will publish Q3 / 2021 figures as scheduled on 11 November 2021.



For more information please contact Andreas Cezanne

Related News

  1. Press Releases

    MilliporeSigma Announces Opening of New € 29 Million Biologics Testing Center ...

    MilliporeSigma today announced the opening of a viral clearance (VC) laboratory as part of the first building phase of its new € 29 million China Biologics Testing Center.